

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil mediated immunity (GO:0002446) | 7.43897687 |
| 2 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 7.13010942 |
| 3 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 7.13010942 |
| 4 | cellular extravasation (GO:0045123) | 6.93055973 |
| 5 | negative regulation of growth of symbiont in host (GO:0044130) | 6.66774212 |
| 6 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 6.66774212 |
| 7 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 6.66774212 |
| 8 | regulation of growth of symbiont in host (GO:0044126) | 6.66774212 |
| 9 | response to peptidoglycan (GO:0032494) | 6.49545201 |
| 10 | innate immune response in mucosa (GO:0002227) | 6.30902496 |
| 11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 6.21883967 |
| 12 | defense response to fungus (GO:0050832) | 6.10341639 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.92301005 |
| 14 | myeloid leukocyte mediated immunity (GO:0002444) | 5.85734727 |
| 15 | disruption of cells of other organism (GO:0044364) | 5.63601355 |
| 16 | killing of cells of other organism (GO:0031640) | 5.63601355 |
| 17 | antibacterial humoral response (GO:0019731) | 5.53947546 |
| 18 | response to fungus (GO:0009620) | 5.46006676 |
| 19 | mucosal immune response (GO:0002385) | 5.18528206 |
| 20 | antimicrobial humoral response (GO:0019730) | 5.15407248 |
| 21 | cell wall macromolecule catabolic process (GO:0016998) | 5.11495661 |
| 22 | organ or tissue specific immune response (GO:0002251) | 5.02875702 |
| 23 | negative regulation of interleukin-8 production (GO:0032717) | 5.01598917 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.90559401 |
| 25 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.88130578 |
| 26 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.77331088 |
| 27 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.76325627 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 4.58535722 |
| 29 | neutrophil activation (GO:0042119) | 4.50823616 |
| 30 | detection of other organism (GO:0098543) | 4.47979795 |
| 31 | respiratory burst (GO:0045730) | 4.41227040 |
| 32 | detection of bacterium (GO:0016045) | 4.24065892 |
| 33 | cell wall macromolecule metabolic process (GO:0044036) | 4.19589932 |
| 34 | microglial cell activation (GO:0001774) | 4.17606562 |
| 35 | hydrogen peroxide catabolic process (GO:0042744) | 4.16666707 |
| 36 | negative regulation of phagocytosis (GO:0050765) | 4.14542428 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 4.11348180 |
| 38 | response to muramyl dipeptide (GO:0032495) | 4.09593083 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.04169594 |
| 40 | granulocyte activation (GO:0036230) | 4.02252055 |
| 41 | reactive oxygen species biosynthetic process (GO:1903409) | 3.93128791 |
| 42 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.88265804 |
| 43 | defense response to Gram-positive bacterium (GO:0050830) | 3.81949588 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.80983805 |
| 45 | regulation of leukocyte degranulation (GO:0043300) | 3.78116165 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.72635502 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.72635502 |
| 48 | hemoglobin metabolic process (GO:0020027) | 3.71286741 |
| 49 | macrophage differentiation (GO:0030225) | 3.61522057 |
| 50 | regulation of chemokine biosynthetic process (GO:0045073) | 3.59949423 |
| 51 | definitive hemopoiesis (GO:0060216) | 3.54957087 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.49229152 |
| 53 | angiotensin maturation (GO:0002003) | 3.44773800 |
| 54 | regulation of B cell differentiation (GO:0045577) | 3.44334112 |
| 55 | oxygen transport (GO:0015671) | 3.42672308 |
| 56 | positive regulation of granulocyte differentiation (GO:0030854) | 3.42032014 |
| 57 | cell killing (GO:0001906) | 3.38019090 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.36436875 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.34292676 |
| 60 | regulation of regulated secretory pathway (GO:1903305) | 3.33370534 |
| 61 | leukocyte mediated cytotoxicity (GO:0001909) | 3.31942608 |
| 62 | macrophage activation (GO:0042116) | 3.30638742 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 3.29164627 |
| 64 | leukocyte degranulation (GO:0043299) | 3.28835750 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.21860159 |
| 66 | negative regulation of interleukin-6 production (GO:0032715) | 3.21361422 |
| 67 | defense response to bacterium (GO:0042742) | 3.21063787 |
| 68 | mannose metabolic process (GO:0006013) | 3.17608701 |
| 69 | detection of external biotic stimulus (GO:0098581) | 3.16833284 |
| 70 | leukocyte aggregation (GO:0070486) | 3.15506430 |
| 71 | immunoglobulin mediated immune response (GO:0016064) | 3.13119825 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 3.12970343 |
| 73 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.12504704 |
| 74 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.12260041 |
| 75 | macrophage activation involved in immune response (GO:0002281) | 3.10388452 |
| 76 | negative regulation of interleukin-12 production (GO:0032695) | 3.08845989 |
| 77 | B cell receptor signaling pathway (GO:0050853) | 3.03713072 |
| 78 | regulation of hypersensitivity (GO:0002883) | 3.03533286 |
| 79 | mature B cell differentiation involved in immune response (GO:0002313) | 3.03337605 |
| 80 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.01929822 |
| 81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97795042 |
| 82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97795042 |
| 83 | modulation by symbiont of host immune response (GO:0052553) | 2.97795042 |
| 84 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97795042 |
| 85 | modulation by symbiont of host defense response (GO:0052031) | 2.97795042 |
| 86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97795042 |
| 87 | pinocytosis (GO:0006907) | 2.96269812 |
| 88 | detection of biotic stimulus (GO:0009595) | 2.96158286 |
| 89 | mast cell activation (GO:0045576) | 2.94163349 |
| 90 | response to protozoan (GO:0001562) | 2.91653538 |
| 91 | response to bacterium (GO:0009617) | 2.88231028 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87265898 |
| 93 | regulation of tolerance induction (GO:0002643) | 2.87089009 |
| 94 | hydrogen peroxide metabolic process (GO:0042743) | 2.86950198 |
| 95 | negative regulation of B cell apoptotic process (GO:0002903) | 2.85252089 |
| 96 | superoxide anion generation (GO:0042554) | 2.84710777 |
| 97 | natural killer cell activation involved in immune response (GO:0002323) | 2.83894659 |
| 98 | positive regulation of regulated secretory pathway (GO:1903307) | 2.78877267 |
| 99 | defense response to protozoan (GO:0042832) | 2.75097028 |
| 100 | gas transport (GO:0015669) | 2.74449540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 5.52400367 |
| 2 | VDR_24763502_ChIP-Seq_THP-1_Human | 4.57549963 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.19948857 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.14820475 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.82083424 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.78509933 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.63144495 |
| 8 | * SPI1_23547873_ChIP-Seq_NB4_Human | 3.24090894 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95720727 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.89110847 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.64791806 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.62348244 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.49648574 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.48450281 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.48199761 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44117097 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.43827936 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39564296 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.38043591 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38014332 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.22301849 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21368753 |
| 23 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.21183233 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.17629571 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.16600683 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.15082441 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12272453 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.10982737 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.09808187 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.00432445 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98719342 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86323529 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84777548 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84379943 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.83866649 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82030559 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80913343 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80056244 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76029095 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75597367 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71035097 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70034595 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67532570 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67461181 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66589989 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66224098 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.65940205 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.65367045 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64902285 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62030351 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61244074 |
| 52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.60438351 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.56383684 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.53892270 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53407337 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50878966 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49950038 |
| 58 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46004232 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45657544 |
| 60 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.44280509 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42087754 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39767525 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38006760 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37707353 |
| 65 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34840783 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34242342 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33898484 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33082714 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32382122 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23748204 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23014216 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20959593 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19604977 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19266245 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17762533 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17198752 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16583618 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16455538 |
| 79 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16227123 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15659470 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14428381 |
| 82 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14312955 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13622072 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13314110 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13247395 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12167116 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11403087 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11349645 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08976971 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.07695460 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07272448 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06684433 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03118148 |
| 94 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.01883215 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00628368 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99870652 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99864560 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98617173 |
| 99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95662260 |
| 100 | P300_27268052_Chip-Seq_Bcells_Human | 0.95586293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.52111231 |
| 2 | MP0003436_decreased_susceptibility_to | 3.60337327 |
| 3 | MP0002419_abnormal_innate_immunity | 3.38601632 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.38354926 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.38081139 |
| 6 | MP0005025_abnormal_response_to | 3.07646526 |
| 7 | MP0005464_abnormal_platelet_physiology | 2.86430031 |
| 8 | MP0009278_abnormal_bone_marrow | 2.79529691 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.77844606 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.71960316 |
| 11 | MP0001545_abnormal_hematopoietic_system | 2.65262396 |
| 12 | MP0005397_hematopoietic_system_phenotyp | 2.65262396 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.61287570 |
| 14 | MP0009785_altered_susceptibility_to | 2.37724029 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.32107290 |
| 16 | MP0003724_increased_susceptibility_to | 2.31570764 |
| 17 | MP0001819_abnormal_immune_cell | 2.28053350 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.20109930 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.19085607 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.17475072 |
| 21 | MP0001800_abnormal_humoral_immune | 2.17086611 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.06577580 |
| 23 | MP0006082_CNS_inflammation | 2.04877155 |
| 24 | MP0002398_abnormal_bone_marrow | 2.04018813 |
| 25 | MP0002723_abnormal_immune_serum | 2.00254983 |
| 26 | MP0002009_preneoplasia | 1.97433737 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.94963134 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 1.88663591 |
| 29 | MP0000015_abnormal_ear_pigmentation | 1.86353823 |
| 30 | MP0000716_abnormal_immune_system | 1.83276541 |
| 31 | MP0000685_abnormal_immune_system | 1.82536161 |
| 32 | MP0004147_increased_porphyrin_level | 1.81836573 |
| 33 | MP0003828_pulmonary_edema | 1.81689096 |
| 34 | MP0002722_abnormal_immune_system | 1.75398134 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.75395746 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.72138653 |
| 37 | MP0002405_respiratory_system_inflammati | 1.69460935 |
| 38 | MP0001853_heart_inflammation | 1.65815644 |
| 39 | MP0005671_abnormal_response_to | 1.65320091 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.64545979 |
| 41 | MP0005387_immune_system_phenotype | 1.63876755 |
| 42 | MP0001790_abnormal_immune_system | 1.63876755 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.63654670 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.62984326 |
| 45 | MP0002429_abnormal_blood_cell | 1.62639919 |
| 46 | MP0001851_eye_inflammation | 1.61690560 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.59411614 |
| 48 | MP0002132_abnormal_respiratory_system | 1.58552422 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.57425578 |
| 50 | MP0009764_decreased_sensitivity_to | 1.53749613 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.44138684 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.31293711 |
| 53 | MP0008260_abnormal_autophagy | 1.27468395 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.26435527 |
| 55 | MP0002006_tumorigenesis | 1.23247016 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.23002181 |
| 57 | MP0004947_skin_inflammation | 1.22418619 |
| 58 | MP0008469_abnormal_protein_level | 1.22403900 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.21210574 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.16567320 |
| 61 | MP0009379_abnormal_foot_pigmentation | 1.15134919 |
| 62 | MP0003075_altered_response_to | 1.08826318 |
| 63 | MP0005083_abnormal_biliary_tract | 1.04732676 |
| 64 | MP0005164_abnormal_response_to | 1.04290144 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.01375570 |
| 66 | MP0009763_increased_sensitivity_to | 0.97548346 |
| 67 | MP0000858_altered_metastatic_potential | 0.97030383 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.95301800 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.95006974 |
| 70 | MP0004883_abnormal_blood_vessel | 0.94781368 |
| 71 | MP0002095_abnormal_skin_pigmentation | 0.94389930 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.94306024 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.92007736 |
| 74 | MP0008057_abnormal_DNA_replication | 0.90294439 |
| 75 | MP0005390_skeleton_phenotype | 0.88438314 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.86025299 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.84760091 |
| 78 | MP0003866_abnormal_defecation | 0.83016159 |
| 79 | MP0000681_abnormal_thyroid_gland | 0.80817166 |
| 80 | MP0004381_abnormal_hair_follicle | 0.78596174 |
| 81 | MP0008007_abnormal_cellular_replicative | 0.76350987 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 0.73503220 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.72360398 |
| 84 | MP0008873_increased_physiological_sensi | 0.67274201 |
| 85 | MP0000249_abnormal_blood_vessel | 0.66438258 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.66437698 |
| 87 | MP0003795_abnormal_bone_structure | 0.66229644 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.64479169 |
| 89 | MP0000343_altered_response_to | 0.63651135 |
| 90 | MP0001663_abnormal_digestive_system | 0.63157763 |
| 91 | MP0000598_abnormal_liver_morphology | 0.60791435 |
| 92 | MP0005166_decreased_susceptibility_to | 0.60523653 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.58681634 |
| 94 | MP0000490_abnormal_crypts_of | 0.55948178 |
| 95 | MP0009931_abnormal_skin_appearance | 0.55417038 |
| 96 | MP0003448_altered_tumor_morphology | 0.54429777 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.54192088 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54127095 |
| 99 | MP0008995_early_reproductive_senescence | 0.53959012 |
| 100 | MP0005165_increased_susceptibility_to | 0.52903425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.50082979 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.44695959 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 5.39004468 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.02867734 |
| 5 | Thrombocytosis (HP:0001894) | 4.99259152 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.65888201 |
| 7 | Obstructive lung disease (HP:0006536) | 4.65822033 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 4.65822033 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.32524340 |
| 10 | Myositis (HP:0100614) | 4.26581668 |
| 11 | Amyloidosis (HP:0011034) | 4.26322511 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.06985868 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.06440195 |
| 14 | Granulocytopenia (HP:0001913) | 4.00282727 |
| 15 | Stomatitis (HP:0010280) | 3.79970488 |
| 16 | Recurrent skin infections (HP:0001581) | 3.79811466 |
| 17 | Meningitis (HP:0001287) | 3.78740913 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.71767334 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.68925181 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.68925181 |
| 21 | Hypochromic anemia (HP:0001931) | 3.66661380 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61307669 |
| 23 | Abnormality of the prostate (HP:0008775) | 3.57246450 |
| 24 | Acute lymphatic leukemia (HP:0006721) | 3.53743049 |
| 25 | Prolonged bleeding time (HP:0003010) | 3.49047713 |
| 26 | Epistaxis (HP:0000421) | 3.37305763 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.37285114 |
| 28 | Microcytic anemia (HP:0001935) | 3.19178730 |
| 29 | Chest pain (HP:0100749) | 3.16610601 |
| 30 | Periodontitis (HP:0000704) | 3.15988077 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.10880210 |
| 32 | Cellulitis (HP:0100658) | 3.03573564 |
| 33 | Petechiae (HP:0000967) | 3.00623658 |
| 34 | Abnormality of iron homeostasis (HP:0011031) | 3.00086069 |
| 35 | Gingivitis (HP:0000230) | 2.99505463 |
| 36 | Acute myeloid leukemia (HP:0004808) | 2.97191585 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.95956644 |
| 38 | Eosinophilia (HP:0001880) | 2.95837488 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.95077970 |
| 40 | Recurrent viral infections (HP:0004429) | 2.91509229 |
| 41 | Hemoptysis (HP:0002105) | 2.85031485 |
| 42 | Osteomyelitis (HP:0002754) | 2.84730245 |
| 43 | Increased serum ferritin (HP:0003281) | 2.81805417 |
| 44 | Orchitis (HP:0100796) | 2.81765461 |
| 45 | Leukocytosis (HP:0001974) | 2.81396378 |
| 46 | Urticaria (HP:0001025) | 2.79131171 |
| 47 | Vasculitis (HP:0002633) | 2.76940792 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.76864135 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.74999237 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.74009008 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.72112604 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.70770033 |
| 53 | Gingival bleeding (HP:0000225) | 2.70494111 |
| 54 | Skin rash (HP:0000988) | 2.63736451 |
| 55 | Spondylolisthesis (HP:0003302) | 2.63309346 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.63211384 |
| 57 | Optic neuritis (HP:0100653) | 2.63211384 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.60030826 |
| 59 | Increased IgE level (HP:0003212) | 2.59763281 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.59702859 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.55377467 |
| 62 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.52472705 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.50069875 |
| 64 | Thoracic kyphosis (HP:0002942) | 2.46356112 |
| 65 | Encephalitis (HP:0002383) | 2.44849398 |
| 66 | Thrombophlebitis (HP:0004418) | 2.43380559 |
| 67 | Polycythemia (HP:0001901) | 2.41882141 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.40830069 |
| 69 | B lymphocytopenia (HP:0010976) | 2.40743089 |
| 70 | Abnormal hemoglobin (HP:0011902) | 2.39286328 |
| 71 | Skin ulcer (HP:0200042) | 2.37773366 |
| 72 | Sepsis (HP:0100806) | 2.37381464 |
| 73 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.34027024 |
| 74 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.34027024 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.34027024 |
| 76 | Pulmonary embolism (HP:0002204) | 2.31608134 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.26743338 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.23689062 |
| 79 | Arterial thrombosis (HP:0004420) | 2.23099389 |
| 80 | Abnormality of eosinophils (HP:0001879) | 2.20612740 |
| 81 | Episodic fever (HP:0001954) | 2.20450341 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.17627603 |
| 83 | Poikilocytosis (HP:0004447) | 2.16491738 |
| 84 | Glomerulopathy (HP:0100820) | 2.14340287 |
| 85 | Inflammation of the large intestine (HP:0002037) | 2.13379819 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.11486729 |
| 87 | Paralysis (HP:0003470) | 2.10149217 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.09845270 |
| 89 | Gangrene (HP:0100758) | 2.08937196 |
| 90 | Pallor (HP:0000980) | 2.08415369 |
| 91 | Autoimmune hemolytic anemia (HP:0001890) | 2.07398793 |
| 92 | Abnormality of male internal genitalia (HP:0000022) | 2.06416312 |
| 93 | Abnormality of T cells (HP:0002843) | 2.04591265 |
| 94 | Paresthesia (HP:0003401) | 2.03598722 |
| 95 | Impaired platelet aggregation (HP:0003540) | 2.03386036 |
| 96 | Abnormal platelet function (HP:0011869) | 2.03386036 |
| 97 | Colitis (HP:0002583) | 2.03069690 |
| 98 | Pulmonary fibrosis (HP:0002206) | 2.02083730 |
| 99 | Keratoconjunctivitis (HP:0001096) | 2.02023048 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00711466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.40870772 |
| 2 | MAP2K3 | 3.63006490 |
| 3 | FES | 3.31349595 |
| 4 | PRPF4B | 2.77763468 |
| 5 | GRK6 | 2.75205575 |
| 6 | TEC | 2.72158978 |
| 7 | TESK2 | 2.50956200 |
| 8 | KIT | 2.43843747 |
| 9 | BLK | 2.43297378 |
| 10 | ERN1 | 2.35961441 |
| 11 | BTK | 2.34926568 |
| 12 | MAP4K1 | 2.25297368 |
| 13 | TNK2 | 2.15256346 |
| 14 | SYK | 2.07492117 |
| 15 | TYK2 | 2.03530888 |
| 16 | ZAP70 | 1.99502521 |
| 17 | IRAK4 | 1.82501121 |
| 18 | MAP3K6 | 1.78397253 |
| 19 | PIK3CG | 1.77584325 |
| 20 | TBK1 | 1.68763329 |
| 21 | TRPM7 | 1.64829211 |
| 22 | CSF1R | 1.54620331 |
| 23 | HCK | 1.49759889 |
| 24 | FLT3 | 1.47358042 |
| 25 | LYN | 1.47342243 |
| 26 | CDK6 | 1.43461237 |
| 27 | TAOK3 | 1.40179311 |
| 28 | CDK19 | 1.38387347 |
| 29 | MAP3K14 | 1.34732041 |
| 30 | BMPR2 | 1.32300948 |
| 31 | MAP3K11 | 1.30740042 |
| 32 | ITK | 1.30306709 |
| 33 | CDK12 | 1.25045382 |
| 34 | TAOK1 | 1.23972414 |
| 35 | MOS | 1.22613874 |
| 36 | TAOK2 | 1.19541637 |
| 37 | TRIB3 | 1.08714579 |
| 38 | SCYL2 | 1.07041441 |
| 39 | GRK7 | 1.00361772 |
| 40 | CSK | 0.97210973 |
| 41 | TXK | 0.95249948 |
| 42 | LCK | 0.94393045 |
| 43 | JAK2 | 0.94216312 |
| 44 | MAP3K3 | 0.93626873 |
| 45 | IKBKE | 0.92435245 |
| 46 | HIPK2 | 0.92333496 |
| 47 | ABL2 | 0.91270414 |
| 48 | IKBKB | 0.90820427 |
| 49 | MAPK4 | 0.88609665 |
| 50 | MAP3K13 | 0.87948418 |
| 51 | TGFBR2 | 0.86975252 |
| 52 | MAP3K1 | 0.84923837 |
| 53 | KDR | 0.81886540 |
| 54 | RPS6KA4 | 0.80875244 |
| 55 | JAK3 | 0.79706675 |
| 56 | STK10 | 0.77824037 |
| 57 | PDK1 | 0.77598290 |
| 58 | CDK4 | 0.74192847 |
| 59 | MARK3 | 0.71625214 |
| 60 | MATK | 0.69789862 |
| 61 | RPS6KC1 | 0.69105488 |
| 62 | RPS6KL1 | 0.69105488 |
| 63 | LRRK2 | 0.68050917 |
| 64 | PDPK1 | 0.65519522 |
| 65 | RPS6KA6 | 0.61488738 |
| 66 | MAP2K6 | 0.61360420 |
| 67 | MAP3K5 | 0.61249798 |
| 68 | MAP2K2 | 0.60758648 |
| 69 | PIM1 | 0.60635613 |
| 70 | MAP2K4 | 0.59968249 |
| 71 | FGR | 0.58731821 |
| 72 | YES1 | 0.58215961 |
| 73 | IRAK2 | 0.55687838 |
| 74 | MAPK12 | 0.55255274 |
| 75 | PRKCQ | 0.54335500 |
| 76 | BCKDK | 0.53331934 |
| 77 | EEF2K | 0.52339069 |
| 78 | RPS6KB2 | 0.50138250 |
| 79 | ABL1 | 0.46183735 |
| 80 | MARK2 | 0.45909848 |
| 81 | IRAK1 | 0.44354890 |
| 82 | MAPK7 | 0.42391812 |
| 83 | TLK1 | 0.40576650 |
| 84 | MAPKAPK2 | 0.40491929 |
| 85 | VRK2 | 0.39788828 |
| 86 | GSK3A | 0.39429872 |
| 87 | PLK4 | 0.38634681 |
| 88 | VRK1 | 0.37338555 |
| 89 | IRAK3 | 0.36116877 |
| 90 | MAPK3 | 0.34627534 |
| 91 | MAPK11 | 0.34343793 |
| 92 | RPS6KA5 | 0.34150271 |
| 93 | PRKCD | 0.33863394 |
| 94 | PKN2 | 0.32628682 |
| 95 | RET | 0.32477761 |
| 96 | MAPK15 | 0.31060375 |
| 97 | FYN | 0.29150249 |
| 98 | STK11 | 0.28478895 |
| 99 | CLK1 | 0.27959621 |
| 100 | PIK3CA | 0.25941605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.44418719 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.66695069 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.91932916 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48554183 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33843216 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.31368258 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.25836144 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.09852412 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08658989 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.90420098 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.83847108 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.83664580 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.83550044 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77822015 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.72779307 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.66701667 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56846867 |
| 18 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.54643284 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54297197 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.53414679 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52447767 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.51402189 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.50482864 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.50400563 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46163009 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.44403530 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39405529 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.38610504 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.38203528 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33232982 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33219151 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.31916424 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.30652837 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30621190 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.27587377 |
| 36 | Ribosome_Homo sapiens_hsa03010 | 1.24668957 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.16776019 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16123950 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13555541 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.12630649 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.12371219 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11479359 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09678332 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09486262 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07959754 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07817502 |
| 47 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.07658473 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04526778 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.03626267 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01961714 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.99420361 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95894759 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94143973 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93395751 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92010706 |
| 56 | Base excision repair_Homo sapiens_hsa03410 | 0.91527645 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91495134 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91380489 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88661732 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87868038 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85071839 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81345590 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80907123 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79551315 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.79350002 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.78717183 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74269157 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66619469 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66364293 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62525778 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58929693 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.58336238 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56892946 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56855348 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56429886 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.55854641 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54656852 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54495892 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51177905 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48768099 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47911679 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46810145 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46418655 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46299705 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40586477 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39950783 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37995906 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36766039 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35781175 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35589458 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34778760 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33758801 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.33280154 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.32471906 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.30897783 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30485124 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30194525 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30094138 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28854194 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28094465 |

